Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02712788 · ClinicalTrials.gov registry record · Phase 2
Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
A Phase 2 study, sponsored by Indiana University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT02712788 is a Phase 2 study that was terminated before completion, run by Indiana University. The registered enrollment target is 4 participants.
The verdict
NCT02712788, a Phase 2 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the usefulness of adding Milrinone to the current standard treatment for cerebral vasospasm.
Interventions
- DRUG Placebo
- DRUG Milrinone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-04-18 |
| Est. Completion | 2018-05-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02712788
The ClinicalTrials.gov registry entry for NCT02712788 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02712788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02712788 about?
NCT02712788 is a clinical study titled "Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage". The purpose of this study is to evaluate the usefulness of adding Milrinone to the current standard treatment for cerebral vasospasm.
What is the current status of trial NCT02712788?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2016-04-18. Estimated completion is 2018-05-03.
What interventions are being tested in trial NCT02712788?
The interventions under investigation include: Placebo (DRUG), Milrinone (DRUG).
Who is sponsoring clinical trial NCT02712788?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.